Bio-Thera Solutions, Ltd

Bio-Thera to Present Phase 2 Clinical Data for BAT8008 in Combination with BAT1308 at ESMO 2026

Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced…